(Q46228211)

20 December 2017

title

Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality (English)

1 reference

20 December 2017

0 references

1 reference

1 reference

Juan M López-Gómez

1

1 reference

20 December 2017

José M Portolés

series ordinal

2

1 reference

20 December 2017

Pedro Aljama

series ordinal

3

1 reference

20 December 2017

publication date

1 December 2008

1 reference

20 December 2017

Kidney International. Supplement

published in

1 reference

20 December 2017

issue

111

1 reference

20 December 2017

page(s)

S75-81

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1038/ki.2008.523

exact match

0 references

cites work

Clinical factors influencing sensitivity and response to epoetin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

The inflammatory response and epoetin sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity--the experience of the Lombardy Dialysis Registry

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Exploring relative mortality and epoetin alfa dose among hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Challenging the validity of the EPO index

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Balance between pro-inflammatory cytokines and their specific inhibitors in patients on dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Pathogenesis and treatment of the anemia of chronic disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

The efficacy of rHuEPO in cancer-related anaemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Inflammation in end-stage renal disease: sources, consequences, and therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Gender modulates responsiveness to recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Haemoglobin and ferritin concentrations in men and women: cross sectional study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Working capacity is increased following recombinant human erythropoietin treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Decreased erythropoietin response in patients with the anemia of cancer

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Vascular access and increased risk of death among hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Course of vascular access and relationship with treatment of anemia.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Role of type of vascular access in erythropoietin and intravenous iron requirements in haemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Infectious complications of old nonfunctioning arteriovenous grafts in renal transplant recipients: a case series

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Update on interleukin-6 and its role in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Improved iron utilization and reduced erythropoietin resistance by on-line hemodiafiltration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Subcutaneous versus intravenous administration of erythropoietin improves its efficiency for the treatment of anaemia in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.523

7 January 2021

Identifiers

DOI

10.1038/KI.2008.523

1 reference

20 December 2017

Dimensions Publication ID

1039103769

0 references

1 reference

20 December 2017